Downloads
Up

General

Informational documents regarding Endometrial Stromal Sarcoma.

 

2009 State of the State of Gynecological Cancers by the Gynecologic Cancer Foundation.
Soft tissue sarcomas are a heterogeneous group of diseases that share a mesenchymal origin. Despite this heterogeneity, these tumors have always been pooled together in clinical studies and treated as if they were all the same. This issue of Journal of Clinical Oncology features five articles that each, in their own way, indicate that soft tissue sarcoma trial design should considerably be changed in future studies.
Soft tissue sarcomas (STSs) account for less than 1% of all the malignant tumours occurring in the female tract. Nevertheless, attention needs to be given to these tumours given the important differences in their management compared with more common gynaecological malignancies.
Hypothetically, any site in a radiation portal has potential for late malignant transformation. Secondary malignant neoplasms may occur after almost any index cancer has been treated with radiation and/or chemotherapy.
A 63-year-old female with a well-vascularized pulmonary metastasis of an endometrial stromal sarcoma (ESS) of 6x6 cm received selective embolization with 150-250 µm polyvinyl alcohol (Contour; Boston Scientific, Natick, MA, USA) via a bronchial artery.
Basic information regarding Uterine Sarcomas from the American Cancer Society.
A report on advances for advanced disease and adjuvant therapy that was presented at the 2006 American Society of Clinical Oncology (ASCO) meeting.
Case study on one high grade Uterine Sarcoma presented in Diagnosis in Oncology, 2000.
Display Num 
Powered by Phoca Download